arenavirus
import
caus
viral
hemorrhag
fever
human
arenaviru
infect
cell
occur
via
ph
depend
endocyt
rout
detail
studi
entri
pathway
done
investig
role
cell
membran
cholesterol
caveola
clathrin
coat
pit
infect
lassa
viru
lasv
util
alphadystroglycan
receptor
viru
picv
deplet
cellular
cholesterol
treatment
methyl
betacyclodextrin
nystatinprogesteron
inhibit
picv
replic
transfer
packag
marker
gene
lasv
picv
pseudotyp
retrovir
particl
cell
lack
caveola
due
silenc
gene
inhibit
picv
infect
lasv
pseudotyp
transduct
observ
howev
picv
infect
lasv
picv
pseudotyp
transduct
inhibit
domin
neg
mutant
use
inhibit
clathrinmedi
endocytosi
altogeth
result
indic
divers
arenavirus
common
requir
cell
membran
cholesterol
clathrin
mediat
endocytosi
establish
infect
arenavirus
rodentborn
envelop
rna
virus
sever
caus
hemorrhag
fever
syndrom
human
mainli
area
tropic
africa
latin
america
arenaviru
hemorrhag
fever
lassa
fever
preval
affect
approxim
quarter
million
individu
endem
region
west
africa
annual
fisherhoch
mccormick
mccormick
et
al
capac
persontoperson
spread
lack
practic
readili
avail
diagnost
test
limit
therapeut
option
lassa
viru
includ
list
categori
prioriti
pathogen
biodefens
research
borio
et
al
like
highli
hazard
virus
hemorrhag
fevercaus
arenavirus
well
studi
henc
mani
basic
mechan
life
cycl
infect
cell
elucid
particular
signific
gap
exist
knowledg
mechan
cellular
uptakevir
entri
event
could
provid
target
antivir
therapeut
approach
cellular
entri
initi
virus
bind
cellular
receptor
via
surfac
glycoprotein
arenavirus
possess
surfac
spike
compos
trimer
subunit
noncoval
attach
transmembran
stalk
compris
trimer
burn
buchmeier
eschli
et
al
respons
receptor
bind
wherea
drive
fusion
virion
membran
cellular
membran
glushakova
et
al
glushakova
et
al
lamininbind
protein
alphadystroglycan
function
receptor
lassa
viru
well
prototyp
viru
lymphocyt
choriomening
viru
lcmv
cao
et
al
pathogen
new
world
arenavirus
junin
guanarito
machupo
recent
shown
util
cellular
transferrin
receptor
tfr
viral
entri
radoshitzki
et
al
arenaviru
infect
phdepend
glushakova
lukashevich
may
requir
dissoci
low
ph
expos
fusogen
domain
trigger
penetr
di
simon
et
al
di
simon
buchmeier
unlik
major
virus
exhibit
phdepend
entri
old
world
arenaviru
lcmv
appear
util
clathrinmedi
endocyt
rout
judg
ultrastructur
studi
show
lcmv
intern
smoothwal
vesicl
borrow
oldston
howev
recent
evid
implic
clathrinmedi
endocytosi
junin
viru
entri
martinez
et
al
whether
arenavirus
util
clathrinmedi
endocyt
pathway
remain
determin
recent
shown
deplet
cellular
cholesterol
inhibit
infect
prototyp
arenaviru
lcmv
shah
et
al
among
cholesteroldepend
entri
pathway
util
lipid
raft
caveola
best
studi
marsh
heleniu
pelkman
heleniu
caveola
lipid
raft
cholesterol
glycosphingolipid
enrich
plasma
membran
microdomain
insolubl
nonion
deterg
implic
modul
cell
adhes
membran
traffick
pathogen
entri
signal
transduct
brown
london
hakomori
et
al
hakomori
et
al
simon
ikonen
caveola
identifi
stabl
invagin
plasma
membran
enrich
caveolin
cholesterolbind
membran
protein
express
caveolin
shown
suffici
produc
caveola
cell
lipardi
et
al
endocyt
pathway
lead
caveola
neutral
ph
smooth
er
golgi
util
virus
pietiainen
et
al
coxsacki
viru
triantafil
triantafil
howev
also
exampl
phdepend
virus
requir
caveolaelipid
raft
entri
filovirus
bavari
et
al
schornberg
et
al
takada
et
al
avail
experiment
evid
entri
old
world
arenaviru
lcmv
therefor
suggest
potenti
novel
phdepend
cholesteroldepend
pathway
goal
studi
clarifi
role
cholesterol
caveolar
clathrinmedi
endocyt
pathway
cellular
infect
repres
old
world
new
world
arenavirus
pseudotyp
surrog
two
arenavirus
studi
guinea
pigpassag
viru
picv
variant
caus
hemorrhag
fever
guinea
pig
jahrl
et
al
zhang
et
al
util
alphadystroglycan
receptor
rojek
et
al
lassapseudotyp
murin
leukemia
viru
lasvmlv
enter
alphadystroglycan
depend
mechan
show
cholesterol
requir
cellular
infect
picv
lasvmlv
pseudotyp
sever
relev
cell
type
independ
mechan
effect
cholesterol
deplet
infect
level
entri
addit
data
suggest
entri
picv
lasvmlv
pseudotyp
host
cell
occur
clathrinmedi
endocyt
pathway
determin
whether
remov
cholesterol
affect
infect
cell
arenaviru
picv
plaqu
reduct
assay
viral
growth
curv
perform
treatment
cell
shown
remov
cell
membran
cholesterol
beer
et
al
carrasco
et
al
choi
et
al
danthi
chow
simon
ehehalt
vero
cell
pretreat
prior
exposur
picv
reduct
plaqu
number
seen
figur
residu
plaqu
vero
cell
smaller
p
untreat
vero
cell
cultur
data
shown
cell
reconstitut
cholesterol
prior
addit
viru
plaqu
number
restor
control
level
treatment
vero
cell
signific
effect
vesicular
stomat
viru
vsv
plaqu
format
treatment
vero
cell
nystatinprogesteron
nysprog
disrupt
cholesterol
enrich
domain
specif
bind
cholesterol
interf
cholesterol
synthesi
also
inhibit
picv
infect
incub
cell
nysprog
result
reduct
plaqu
number
similar
vero
cell
without
affect
vsv
plaqu
format
fig
vsv
infect
known
occur
via
clathrinmedi
endocytosi
sun
et
al
sensit
membran
cholesterol
deplet
danthi
chow
control
also
rule
signific
druginduc
cytox
also
studi
effect
host
cellular
cholesterol
deplet
picv
yield
infect
cell
picv
yield
h
post
infect
cell
reduc
compar
untreat
cell
fig
inhibit
observ
vero
cell
cell
murin
macrophagelik
cell
line
reconstitut
cholesterol
cell
prior
viral
infect
restor
viral
yield
control
level
pretreat
cell
nysprog
also
result
inhibit
picv
yield
infect
vero
cell
cell
fig
titer
vsv
unaffect
nysprog
treatment
vero
cell
later
time
point
h
infect
cell
incub
presenc
complet
media
cholesterol
contain
serum
signific
differ
picv
titer
observ
cell
untreat
cell
cultur
gener
pfuml
data
shown
approxim
cellular
cholesterol
remov
treatment
fig
cholesterol
reconstitut
cell
slightli
increas
cholesterol
level
compar
untreat
control
cell
fig
effect
treatment
synthesi
viral
protein
cell
infect
picv
test
experi
viral
protein
synthesi
assay
immunoblot
analysi
use
polyclon
antipeptid
antibodi
gpc
recogn
glycoprotein
precursor
gpc
kda
kda
monoclon
antibodi
recogn
nucleoprotein
np
kda
picv
product
picv
gpc
np
vero
cell
reduc
compar
untreat
vero
cell
h
post
infect
fig
addit
cholesterol
vero
cell
prior
viru
infect
led
increas
synthesi
viral
protein
compar
vero
cell
level
cellular
tfr
unaffect
drug
treatment
viru
infect
result
indic
synthesi
viral
protein
reduc
cholesteroldeplet
cell
determin
whether
cholesterol
deplet
primarili
inhibit
earli
event
viral
life
cycl
vero
cell
treat
variou
time
point
rel
addit
viru
min
prior
addit
viru
min
addit
viru
min
addit
viru
fig
immunoblot
analysi
perform
assay
viral
protein
level
viral
protein
np
gpc
decreas
cell
treat
min
prior
min
addit
viru
fig
howev
ad
min
viru
addit
littl
effect
amount
viral
protein
produc
correspond
reduct
viral
titer
h
post
infect
observ
fig
altogeth
data
suggest
cholesterol
deplet
target
cell
affect
earli
event
viru
life
cycl
determin
whether
cholesterol
deplet
affect
viral
entri
per
se
replic
defici
arenaviru
pseudotyp
retrovirus
use
use
picv
lasvenvelop
protein
pseudotyp
particl
analys
retrovir
pseudotyp
allow
work
perform
laboratori
set
isol
envelop
function
viral
compon
function
character
picv
lasvmlv
pseudotyp
dg
control
hemizyg
murin
es
dg
dg
knockout
murin
es
dg
cell
line
shah
et
al
zhan
et
al
transduc
picv
lasv
envmlv
pseudotyp
fig
lasv
old
world
arenaviru
shown
infect
cell
depend
manner
wherea
picv
new
world
clade
arenaviru
infect
occur
independ
rojek
et
al
spiropoul
et
al
expect
lasvmlv
pseudotyp
transduc
es
dg
cell
significantli
better
es
dg
agreement
publish
report
rojek
et
al
kunz
et
al
kunz
et
al
howev
signific
differ
observ
among
es
dg
es
dg
transduc
picvmlv
pseudotyp
demonstr
picvmlv
pseudotyp
similar
clade
b
human
pathogen
virus
requir
infect
differ
observ
infect
es
dg
es
dg
cell
line
control
vsvmlv
pseudotyp
picv
lasvmlv
pseudotyp
use
infect
untreat
vero
cell
fig
treatment
cell
prior
exposur
picv
lasvmlv
pseudotyp
viru
result
inhibit
transduct
respect
compar
untreat
cell
furthermor
reconstitut
cholesterol
cell
restor
picv
lasvmlv
pseudotyp
transduct
howev
treat
cell
minim
effect
entri
pseudotyp
viru
bear
vsvg
envelop
protein
previous
report
vsv
shah
et
al
yonezawa
et
al
therefor
conclud
entri
picv
lasv
requir
cell
membran
cholesterol
test
whether
entri
picv
lasvmlv
pseudotyp
mediat
caveolar
pathway
util
human
hepatoma
cell
lack
function
caveola
damm
et
al
vainio
et
al
observ
lasvmlv
pseudotyp
picv
infect
cell
tabl
well
infect
vero
cell
addit
vero
cell
transfect
sirna
result
silenc
cellular
fig
readili
infect
picv
lasvmlv
pseudotyp
fig
demonstr
lasvmlv
picv
entri
host
cell
primarili
depend
caveola
recent
shown
clade
b
arenavirus
junin
machupo
guanarito
bind
cellular
tfr
radoshitzki
et
al
viral
entri
uptak
natur
ligand
transferrin
occur
via
clathrinco
pit
therefor
studi
contribut
clathrinmedi
endocytosi
arenaviru
entri
egfr
pathway
substrat
clone
constitu
clathrinco
pit
requir
clathrinco
pit
assembl
function
benmerah
et
al
use
domin
neg
mutant
encod
mutant
gfp
fusion
protein
inhibit
clathrinmedi
endocytosi
benmerah
et
al
use
amaxa
nucleofector
ii
describ
materi
method
section
measur
vero
cell
express
gfp
transfect
data
shown
observ
signific
reduct
picv
replic
vero
cell
transfect
compar
untreat
infectedvero
cell
infectedvero
cell
transfect
empti
vector
control
plasmid
fig
vsv
use
posit
control
show
expect
inhibit
infect
cell
immunoblot
analysi
demonstr
reduct
picv
gpc
vero
cell
transfect
compar
picvinfect
cell
transfect
empti
vector
control
plasmid
fig
express
marker
gene
transduct
cell
lasvmlv
picvmlv
pseudotyp
also
reduc
transfect
cell
approxim
respect
fig
examin
fluoresc
microscopi
reveal
vast
major
picvmlv
pseudotypetransduc
vero
cell
express
gfp
plasmid
suggest
presenc
dn
mutant
viral
pseudotyp
uptak
inhibit
consid
possibl
inhibitori
effect
cholesterol
deplet
relat
inhibit
clathrinmedi
endocytosi
transferrinreceptor
uptak
although
use
tfr
receptor
picv
yet
describ
determin
whether
cholesterol
deplet
affect
clathrinmedi
uptak
transferrin
treat
cell
expos
fluorescentlabel
transferrin
view
confoc
microscopi
minut
uptak
label
transferrin
qualit
diminish
cell
fig
previous
demonstr
subtil
studi
demonstr
cell
membran
cholesterol
requir
infect
vero
cell
new
world
arenaviru
picv
given
viral
protein
synthesi
viral
product
inhibit
cell
treat
nysprog
effect
due
cytox
replic
control
viru
vsv
unaffect
drug
treatment
cholesterol
restor
target
cell
viru
replic
increas
level
seen
untreat
cell
cholesteroldeplet
drug
shown
addit
effect
cell
influenc
event
downstream
viru
entri
inhibit
calcium
channel
liu
et
al
two
line
evid
studi
suggest
cellular
cholesterol
requir
earli
event
arenaviru
life
cycl
cellular
cholesterol
deplet
minut
exposur
viru
cell
inhibit
infect
cholesterol
deplet
inhibit
transfer
marker
gene
replic
defect
picv
lasvmlv
pseudotyp
particl
altogeth
result
demonstr
arenaviru
envelop
glycoproteinmedi
entri
host
cell
depend
presenc
cholesterol
cellular
membran
effect
seen
primat
fibroblast
murin
macrophag
type
cell
result
agreement
previous
publish
studi
report
cellular
infect
prototyp
arenaviru
lcmv
could
inhibit
treatment
shah
et
al
extend
observ
arenavirus
macrophagetrop
caus
primarili
hemorrhag
fever
syndrom
suscept
host
effect
similar
lasvmlv
pseudotyp
util
receptor
picv
viru
pseudotyp
rojek
et
al
also
shown
first
time
picv
lasv
pseudotyp
capabl
infect
cell
devoid
indic
arenavirus
enter
cell
noncaveolar
pathway
consist
previou
ultrastructur
studi
lcmv
entri
suggest
viruscontain
smooth
wall
endocyt
vesicl
nm
diamet
borrow
oldston
typic
bigger
caveola
razani
et
al
rule
possibl
multipl
entri
pathway
may
use
simultan
arenavirus
previous
shown
damm
et
al
mechan
cholesterol
may
involv
viral
entri
includ
viru
bind
cellular
receptor
local
within
lipid
raft
microdomain
includ
caveola
noncaveolar
cholesterolenrich
domain
exampl
primari
receptor
constitut
associ
lipid
raft
detect
within
deterg
insolubl
fraction
lyse
cell
kozak
et
al
millan
et
al
disrupt
lipid
raft
cholesterol
remov
result
dispers
cellular
receptor
throughout
cellular
membran
reduc
opportun
multipl
receptor
interact
enhanc
viru
uptak
altern
viral
receptor
may
transient
associ
lipid
raftscaveola
engag
viral
ligand
may
import
viral
endocytosi
triantafil
triantafil
although
well
studi
current
evid
arenaviru
receptor
local
lipid
raft
gpilink
protein
tend
local
concentr
lipid
raft
serv
viral
receptor
new
world
arenavirus
rojek
et
al
tfr
recent
identifi
receptor
new
world
arenavirus
constitut
local
lipid
raft
harder
et
al
lcmv
receptor
cellular
partner
present
deterg
insolubl
domain
suscept
cell
even
lcmv
bind
cell
shah
et
al
conclus
weaken
lack
studi
use
label
lcmv
show
transloc
lipid
raft
nonlipid
raft
fraction
addit
limit
studi
includ
insuffici
sensit
assay
detect
small
relev
amount
variat
proteinlipid
raft
associ
depend
state
cell
kusumi
suzuki
deterg
util
isol
deterg
insolubl
domain
schuck
et
al
howev
observ
arenaviru
infect
requir
caveola
support
conclus
shah
et
al
caveola
normal
associ
lipid
raft
domain
sinc
new
world
arenavirus
guanarito
junin
machupo
util
tfr
receptor
radoshitzki
et
al
sinc
tfr
known
transloc
cellular
surfac
endosom
via
clathrinco
pit
investig
role
clathrinmedi
endocytosi
viru
entri
observ
substanti
inhibit
picv
infect
cell
transfect
dn
mutant
infect
vsv
use
control
ensur
effect
inhibit
clathrinmedi
uptak
domin
neg
mutant
protein
also
diminish
transfect
cell
also
observ
transduct
cell
lasvmlv
picvmlv
pseudotyp
significantli
reduc
cell
express
dn
mutant
demonstr
substanti
reduc
titer
express
pseudotyp
vero
cell
monolay
observ
cell
express
marker
gene
gener
express
mutant
fusion
protein
therefor
believ
reduc
infect
transduct
transfect
cell
larg
occur
cell
maintain
function
find
small
number
doubl
posit
cell
suggest
altern
nonclathrin
pathway
may
support
viral
entri
limit
degre
cellular
uptak
label
transferrin
marker
clathrin
mediat
endocytosi
traffick
put
new
world
arenaviru
receptor
diminish
cholesterol
deplet
cell
howev
drug
treatment
host
cell
affect
total
tfr
level
determin
immunoblot
analysi
classic
virus
util
clathrinmedi
endosom
entri
pathway
less
sensit
cholesterol
deplet
virus
util
caveola
lipid
raft
entri
howev
studi
demonstr
cholesterol
deplet
cell
affect
morpholog
clathrinco
pit
inhibit
detach
coat
pit
plasma
membran
clathrinmedi
endocytosi
subtil
et
al
overal
suggest
picv
enter
cell
clathrinco
pit
cholesterol
deplet
may
inhibit
entri
inhibit
clathrinco
pit
intern
manuscript
review
new
studi
demonstr
new
world
arenaviru
junin
enter
cell
clathrinmedi
endocytosi
agreement
find
martinez
et
al
howev
studi
conclud
junin
entri
moder
inhibit
presenc
nystatin
possibl
junin
viru
clade
b
arenaviru
picv
clade
arenaviru
similar
rout
entri
differ
sensit
cholesterol
deplet
find
clathrinmedi
entri
varianc
older
utrastructur
studi
old
world
arenaviru
lcmv
suggest
lcmv
enter
cell
smoothwal
vesicl
rather
coat
pit
borrow
oldston
data
taken
context
exist
literatur
suggest
possibl
differ
old
world
arenavirus
may
enter
cell
differ
entri
pathway
also
possibl
arenavirus
util
differ
endosom
mechan
entri
differ
cell
type
may
lead
nonproduct
infect
cytoplasm
partner
lassa
viru
receptor
shown
interact
gtpase
dynamin
membran
ruffl
zhan
et
al
result
studi
suggest
role
dystroglycan
regul
clathrinmedi
endocytosi
transferrin
howev
lcmv
bind
infect
cell
depend
kunz
et
al
result
suggest
although
requir
arenaviru
entri
clathrinmedi
endocytosi
requir
intermediari
event
initi
bind
differ
arenavirus
need
studi
altogeth
data
demonstr
picv
lasvmlv
pseudotyp
enter
host
cell
cholesterol
depend
caveolinindepend
clathrinmedi
endocyt
pathway
alphaviru
semliki
forest
viru
sfv
entri
host
cell
mediat
clathrindepend
endocytosi
shown
sensit
cholesterol
deplet
kolokoltsov
et
al
report
cholesterol
sphingolipid
requir
sfv
fusion
host
cell
independ
lipid
raft
ahn
et
al
waart
et
al
propos
entri
picv
lasvmlv
pseudotyp
similar
sfv
entri
sensit
cholesterol
deplet
mediat
clathrindepend
endocytosi
find
may
result
design
therapeut
aim
block
earli
stage
arenaviru
entri
vero
cell
maintain
minim
essenti
medium
cellgro
mediatech
inc
herndon
va
supplement
heatinactiv
fetal
bovin
serum
hyclon
logan
ut
mm
hepe
uml
penicillin
streptomycin
gibco
brl
invitrogen
carlsbad
ca
vero
cell
use
passag
cell
maintain
minim
essenti
medium
supplement
heatinactiv
fetal
bovin
serum
mm
hepe
uml
penicillin
streptomycin
murin
macrophagelik
cell
maintain
rpmi
gibco
brl
supplement
heatinactiv
fetal
bovin
serum
uml
penicillin
streptomycin
cell
maintain
dmem
supplement
fb
uml
penicillin
streptomycin
mous
embryon
stem
cell
defici
es
dg
hemizyg
es
dg
gift
carbonetto
mcgill
univers
health
centr
montreal
quebec
maintain
dmem
fb
uml
penicillin
streptomycin
nonessenti
amino
acid
mm
lglutamin
mm
uml
esgro
serumfre
cultur
medium
contain
cytokin
leukemia
inhibitori
factor
lif
obtain
chemicon
temecula
ca
guinea
pigpassag
variant
picv
strain
coan
develop
peter
jahrl
jahrl
et
al
highpassag
virul
zhang
et
al
util
moi
infect
experi
vesicular
stomat
virusindiana
strain
vsv
indiana
gift
jerrel
univers
nebraska
medic
center
ne
cell
treat
mm
sigmaaldrich
st
loui
mo
dilut
serumfre
dmem
min
respect
cell
vigor
wash
pb
remov
chemic
prior
incub
viru
experi
cell
treat
mm
nystatin
progesteron
sigmaaldrich
overnight
prior
infect
wash
infect
viru
min
viru
incub
stage
media
contain
nystatinprogesteron
ad
nystatin
progesteron
present
durat
experi
postvir
bind
cholesterol
reconstitut
experi
cholesterol
sigmaaldrich
dilut
final
concentr
dmem
fb
ad
cholesteroldefici
cell
hr
cell
wash
prior
addit
viru
cell
harvest
wash
pb
prior
measur
amount
cellular
cholesterol
cholesterol
content
cell
measur
use
amplex
red
cholesterol
assay
molecular
probe
invitrogen
direct
manufactur
fluoresc
measur
biotek
synergi
ht
fluoresc
plateread
nm
equip
biotek
softwar
amount
cellular
cholesterol
calcul
compar
fluoresc
obtain
sampl
fluoresc
obtain
standard
curv
pgagpol
encod
mlv
gag
polymeras
kolokoltsov
et
al
dn
mutant
empti
vector
control
plasmid
invitrogen
kolokoltsov
et
al
gift
dr
r
davey
utmb
galveston
tx
plasmid
use
marker
gene
construct
strategen
la
jolla
ca
encod
flank
mlvltr
packag
sequenc
pvsvg
encod
vsvg
control
cmv
immediateearli
promot
purchas
clonetch
palo
alto
ca
plgp
encod
lasv
josiah
gpc
envelop
orf
vector
gift
buchmeier
scripp
research
institut
ca
construct
encod
picv
envelop
creat
replac
orf
clontech
mountain
view
ca
picv
glycoprotein
precursor
gpc
orf
henc
construct
analog
plgp
gpc
sequenc
first
clone
topo
invitrogen
picv
gpc
insert
flank
sal
restrict
site
gener
pcr
use
follow
primer
forward
cgtactgcggccgcatgggacaagttgtgactttgatccag
revers
ctaggcgtcgacttatttacccagtctcaccc
restrict
site
underlin
gel
purifi
picvgpc
pcr
product
digest
sal
gener
hanger
end
sal
hanger
end
pcr
fragment
purifi
qiagen
valencia
ca
ligat
orf
previous
remov
sal
digest
transform
topo
compet
cell
invitrogen
plasmid
isol
insert
confirm
dna
sequenc
replic
incompet
retrovir
pseudotyp
express
either
lasv
envelop
glycoprotein
picv
envelop
glycoprotein
vsvg
envelop
produc
follow
method
similar
publish
elsewher
kolokoltsov
et
al
cell
plate
one
day
prior
transfect
concentr
cell
per
well
well
plate
next
day
transfect
reagent
miru
corpor
ad
serumfre
media
dmem
gentli
mix
incub
min
room
temperatur
plasmid
dna
purifi
cesium
gradient
qiagen
kit
ad
mixtur
total
dna
ratio
pgagpol
envelop
plasmid
incub
min
room
temperatur
complex
ad
cell
gentli
mix
incub
h
supernat
harvest
filter
micron
filter
ge
osmon
laboratori
remov
cellular
debri
pseudotyp
titer
determin
incub
vero
cell
viruscontain
cultur
supernat
stain
cell
h
xgal
solut
potassium
ferrocyanid
potassium
ferricyanid
mm
xgal
pb
h
posit
foci
count
express
coloni
form
unit
cfu
control
transfect
also
perform
omit
envelop
plasmid
immunoblot
assay
viral
protein
synthesi
perform
use
standard
method
picvinfect
uninfect
cell
primari
antibodi
follow
reagent
use
mous
monoclon
antibodi
recogn
picv
nucleoprotein
np
buchmeier
et
al
donat
dr
buchmeier
scripp
research
institut
ca
polyclon
rabbit
antipeptid
antibodi
gpc
rais
lcmvarm
gpc
sequenc
recogn
picv
lasv
donat
dr
buchmeier
scripp
research
institut
ca
buchmeier
et
al
antitransferrin
receptor
tfr
antibodi
zyme
laboratori
inc
san
francisco
ca
wash
step
incub
appropri
hrpconjug
secondari
antibodi
signal
develop
use
supersign
west
femto
pierc
biotechnolog
inc
rockford
il
substrat
densitometri
perform
least
three
immunoblot
experi
use
onedscan
program
scanalyt
divis
cspi
billerica
viral
protein
band
intens
normal
tfr
express
level
vero
cell
transfect
use
nucleofector
ii
gene
transfer
devic
amaxa
gaithersburg
md
control
sirna
santa
cruz
biotechnolog
santa
cruz
ca
empti
vector
control
plasmid
ad
nucleofector
transfect
kit
v
solut
transfer
vero
cell
instruct
compani
cell
transfer
nucleofector
ii
gene
transfer
devic
electropor
occur
use
program
cell
remov
transfer
plate
incub
h
prior
infect
protein
express
analysi
express
assay
immunoblot
analysi
use
rabbit
polyclon
antibodi
santa
cruz
biotechnolog
observ
gfp
express
transfect
vero
cell
use
egfp
plasmid
provid
compani
transfect
vero
cell
fusion
plasmid
result
gfp
express
cell
drugtreat
untreat
vero
cell
monolay
infect
picv
min
co
humidifi
atmospher
serumfre
mem
follow
wash
pb
remov
unbound
viru
fresh
complet
mem
contain
fb
ad
cell
incub
h
viruscontain
supernat
collect
h
h
h
filter
steril
remov
cellular
debri
standard
plaqu
assay
perform
vero
cell
measur
viru
product
briefli
monolay
expos
viru
min
monolay
overlaid
ml
methylcellulos
contain
eagl
minim
essenti
media
eme
fb
methylcellulos
h
neutral
red
overlay
contain
mm
neutral
red
sigma
aldrich
ad
monolay
h
plaqu
count
plaqu
reduct
assay
drugtreat
untreat
vero
cell
infect
picv
stock
well
plate
min
inoculum
remov
monolay
overlay
methylcellulosecontain
overlay
plaqu
assay
perform
directli
describ
plaqu
number
size
record
vero
cell
incub
molecular
probe
min
prior
paraformaldehyd
fixat
cell
wash
remov
paraformaldehyd
slide
prepar
use
slowfad
gold
antifad
reagent
dapi
molecular
probe
nuclear
stain
zeiss
lsm
meta
confoc
microscop
object
util
visual
dapi
excit
nm
nm
util
excit
nm
use
visual
zeiss
lsm
imag
softwar
use
analyz
imag
result
express
averag
standard
deviat
statist
signific
assess
student
ttest
statist
signific
ascrib
p
respect
infect
env
mlv
pseudotyp
picvmlv
pseudotyp
lasvmlv
pseudotyp
vsvmlv
pseudotyp
posit
foci
count
xgal
stain
b
vero
cell
treat
treat
follow
cholesterol
reconstitut
follow
drug
treatment
cell
expos
dilut
stock
indic
pseudotyp
mlv
prepar
coloni
form
unit
cfu
count
xgal
stain
mean
standard
deviat
triplic
well
indic
experi
repeat
least
time
use
student
ttest
repres
p
picv
lasvmlv
pseudotyp
enter
cell
independ
mechan
vero
cell
transfect
sirna
control
sirna
infect
picv
h
cell
assay
immunoblot
analysi
viral
glycoprotein
product
cellular
cellular
tfr
b
control
sirnatransfect
picv
cell
infect
picv
assay
plaqu
reduct
assay
c
sirna
control
sirnatransfect
cell
infect
lasvmlv
pseudotyp
assay
posit
foci
picv
picvmlv
lasvmlv
pseudotyp
enter
host
cell
clathrindepend
pathway
vero
cell
transfect
empti
vectorcontrol
plasmid
infect
picv
vsv
h
post
transfect
h
supernat
collect
viral
titer
determin
plaqu
assay
b
vero
cell
control
plasmidtransfect
vero
cell
vero
cell
infect
picv
h
viral
glycoprotein
product
assay
immunoblot
analysi
last
lane
repres
picv
gpc
control
demonstr
size
viral
protein
c
lasvmlv
vsvmlv
picvmlv
pseudotyp
use
transduc
vero
cell
vero
cell
transfect
vero
cell
transfect
control
plasmid
cfu
well
count
xgal
stain
mean
standard
deviat
indic
repres
p
student
ttest
untreat
vero
cell
vero
cell
treat
e
f
nysprog
incub
min
follow
paraformaldehyd
fixat
confoc
microscopi
